Warning letter
Pure Herbs Ltd: warning letter of Apr 2, 2014
FDA warning letter 406705 · Detroit District Office
Key facts
| Reference number | 406705 |
|---|---|
| Company | Pure Herbs Ltd |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Apr 2, 2014 |
| Posted date | Oct 14, 2014 |
| Issuing office | Detroit District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101, 101.36, 111, 111.73, 111.510, 101.3(g), 101.4(g), 111.14(b)(2), 111.27(a), 111.35(b)(2), 111.70(b), 111.70(e) and 7 more |
| Inspection city | Sterling Heights |
| Inspection ZIP | 48312 |
| Inspection start date | Apr 23, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: